PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
179.92%
Gross profit growth above 1.5x VALMT.HE's 29.33%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
42.16%
EBIT growth below 50% of VALMT.HE's 87.88%. Michael Burry would suspect deeper competitive or cost structure issues.
42.16%
Operating income growth under 50% of VALMT.HE's 87.88%. Michael Burry would be concerned about deeper cost or sales issues.
-20.26%
Negative net income growth while VALMT.HE stands at 90.32%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-21.30%
Negative EPS growth while VALMT.HE is at 90.48%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-21.30%
Negative diluted EPS growth while VALMT.HE is at 90.24%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.35%
Share count expansion well above VALMT.HE's 0.81%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.35%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-157.58%
Negative OCF growth while VALMT.HE is at 213.16%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-329.13%
Negative FCF growth while VALMT.HE is at 162.75%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-26.92%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.92%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-29.81%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-146.57%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 960.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-146.57%
Negative 5Y OCF/share CAGR while VALMT.HE is at 960.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-152.08%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 960.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
119.59%
Positive 10Y CAGR while VALMT.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
119.59%
Positive 5Y CAGR while VALMT.HE is negative. John Neff might view this as a strong mid-term relative advantage.
-15.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.91%
AR growth well above VALMT.HE's 28.48%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.35%
Inventory growth well above VALMT.HE's 2.55%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.42%
Asset growth above 1.5x VALMT.HE's 0.17%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.74%
Debt growth far above VALMT.HE's 0.47%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.85%
SG&A declining or stable vs. VALMT.HE's 54.55%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.